CClinicalTrials.gg
CompletedNCT03572439Updated Feb 22, 2019

Identification of the Sensory Level Block to Cold During Epidural Analgesia for Labor: A Cohort Study to Determine the Influence of the Direction of Testing

An interventional study of Sensory block level check using ice in Labor Pain, sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Completed at 1 site in Canada. Open to female participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-02-22.

Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
Female
01

Study summary

Assessment of the upper sensory block level during neuraxial analgesia for labor and delivery is an essential component of clinical management and patient safety. A variety of methods have been used for testing the sensory block such as cold, light touch, sharp touch or prick and transcutaneous electrical stimulation. In addition to the diversity of methods, the endpoints used by investigators have also been variable, considering total or partial responses as endpoints. Not surprisingly, a variable sensory block level could be identified as a result of the different methods and types of question asked by the examiner. Another complicating factor is the lack of standardization of the direction of the testing as it relates to anesthetized and non-anesthetized areas. This lack of standardization may result in a difference of several dermatomes in the level that two different assessors might record for the same patient. Considering a clinical research scenario, it may be difficult to replicate results and implement clinical practices. The objective of this study is to determine the degree of agreement between two methods of assessing the sensory block level to cold in women receiving epidural analgesia for labor (anesthetized to non-anesthetized segments versus non-anesthetized to anesthetized segments).

02

Conditions studied

  • Labor Pain

Browse trials for

Keywords

  • epidural
  • sensory block level
  • dermatome
03

In context

Labor Pain

396 studies on the registry are indexed under Labor Pain; 66 are open to participants now.

This study's enrollment of 30 is below the median of 100 across 326 interventional studies indexed under Labor Pain.

Browse Labor Pain studies →

Lead sponsor

Samuel Lunenfeld Research Institute, Mount Sinai Hospital is the lead sponsor of 135 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • patients who request and have no contraindications to receive epidural analgesia
  • capable of understanding and signing the written informed consent
  • have no language barrier to respond to the level of sensory block assessment
  • have no conditions that could compromise their sensitivity to cold.

Exclusion criteria

Exclusion Criteria:

  • patients who refuse to sign consent
  • epidural analgesia is contraindicated
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    Cephalad to caudal

    Sensory block level check using ice, moving from cephalad to caudal

    Diagnostic Test: Sensory block level check using ice

  • Active comparator
    Caudal to cephalad

    Sensory block level check using ice, moving from caudal to cephalad

    Diagnostic Test: Sensory block level check using ice

Interventions

  • Diagnostic testSensory block level check using ice

    Patients are asked to report when the ice feels as cold as it does on the forehead.

06

What researchers measure

Primary outcomes

  1. The lower sensory block level to cold

    The sensory block level will be defined as: the dermatome at which and below which there is complete loss of sensation to cold

    Time frame: 1 hour

  2. The upper sensory block level to cold

    The sensory block level will be defined as: the dermatome at which and below which there is still partial sensation to cold

    Time frame: 1 hour

Secondary outcomes

  1. Patient satisfaction

    Patients will be asked to report satisfaction with the test done from 0-10 (0=very uncomfortable 10=most comfortable

    Time frame: 20 minutes

  2. The lower sensory block level to cold

    The sensory block level will be defined as: the dermatome at which and below which there is complete loss of sensation to cold

    Time frame: 2 hours

  3. The upper sensory block level to cold

    The sensory block level will be defined as: the dermatome at which and below which there is still partial sensation to cold

    Time frame: 2 hours

07

Study locations

1 site
  • Mount Sinai Hospital
    Toronto, Ontario M5G1X5, Canada
08

References and documents

Publications

  • de Souza Soares EC, Balki M, Downey K, Ye XY, Carvalho JCA. Assessment of sensory block during labour epidural analgesia: a prospective cohort study to determine the influence of the direction of testing. Can J Anaesth. 2022 Jun;69(6):750-755. doi: 10.1007/s12630-022-02228-x. Epub 2022 Mar 14. PubMed 35289377 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 22, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03572439
Lead sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Responsible party
Sponsor
First posted
Jun 28, 2018
Start date
Jul 17, 2018
Primary completion
Jan 10, 2019
Completion
Jan 10, 2019
Last update
Feb 22, 2019

Study contacts

Jose CA Carvalho, MD
principal investigator · MOUNT SINAI HOSPITAL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion